Cargando…
Clinical Outcomes of Everolimus Rechallenge in Patients with Pancreatic Neuroendocrine Neoplasms with No Other Treatment Options
SIMPLE SUMMARY: Pancreatic neuroendocrine neoplasms (PNENs) are a type of pancreatic tumor. Everolimus is an oral inhibitor of the mammalian target of rapamycin (mTOR). Although PNENs respond well to systematic treatment, including everolimus, the treatment options are often exhausted in clinical pr...
Autores principales: | Kurita, Yusuke, Kobayashi, Noritoshi, Hara, Kazuo, Mizuno, Nobumasa, Kuwahara, Takamichi, Okuno, Nozomi, Haba, Shin, Tokuhisa, Motohiko, Hasegawa, Sho, Kubota, Kensuke, Nakajima, Atsushi, Ichikawa, Yasushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688517/ https://www.ncbi.nlm.nih.gov/pubmed/36428761 http://dx.doi.org/10.3390/cancers14225669 |
Ejemplares similares
-
Effectiveness and Prognostic Factors of Everolimus in Patients with Pancreatic Neuroendocrine Neoplasms
por: Kurita, Yusuke, et al.
Publicado: (2022) -
Pathological Findings of the Host Immune Reaction in the Tumor Microenvironment of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Hasegawa, Sho, et al.
Publicado: (2020) -
Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms
por: Hijioka, Susumu, et al.
Publicado: (2016) -
Endoscopic ultrasound-guided hepaticogastrostomy using a novel drill dilator
por: Yamada, Masanori, et al.
Publicado: (2022) -
High-Resolution Probe-Based Confocal Laser Endomicroscopy for Diagnosing Biliary Diseases
por: Koda, Hiroki, et al.
Publicado: (2021)